These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29156910)

  • 21. Evaluation of quality of life outcomes following palliative radiotherapy in bone metastases: A literature review.
    Koufopoulou C; Mosa E; Charalampakis N; Nikolaou M; Tsoukalas N; Nixon I; Hamed Saraireh H; Hajiioannou J; Kardamakis D; Kyrgias G; Tolia M
    J BUON; 2019; 24(5):1747-1760. PubMed ID: 31786834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for overall quality of life in patients with advanced cancer.
    Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
    Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.
    Westhoff PG; Verdam MGE; Oort FJ; Jobsen JJ; van Vulpen M; Leer JWH; Marijnen CAM; de Graeff A; van der Linden YM;
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1391-1398. PubMed ID: 27315664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.
    Harding D; Giles SL; Brown MRD; Ter Haar GR; van den Bosch M; Bartels LW; Kim YS; Deppe M; deSouza NM
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):233-242. PubMed ID: 29317145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases.
    Westhoff PG; de Graeff A; Reyners AK; Monninkhof EM; Rodenhuis CC; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
    Radiother Oncol; 2014 May; 111(2):264-9. PubMed ID: 24746581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-treatment of bone metastases for pain control: 2023 ASTRO education panel.
    Lee SF; Simone CB; Rades D; Wong HCY; Chow E
    Ann Palliat Med; 2024 Jul; 13(4):1154-1160. PubMed ID: 38902990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy Versus 3-Dimensional Conventional Radiation Therapy.
    Wong P; Lambert L; Thanomsack P; Coulombe G; Lambert C; Charpentier AM; Barkati M; Fortin I; Lafontaine J; Roberge D
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1431-1439. PubMed ID: 33259935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
    Westhoff PG; de Graeff A; Monninkhof EM; Pomp J; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):694-701. PubMed ID: 26281825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for psychological distress before radiotherapy for painful bone metastases may be useful to identify patients with high levels of distress.
    Westhoff PG; de Graeff A; Monninkhof EM; Berveling MJ; van Vulpen M; Leer JWH; Marijnen CAM; Reyners AKL; van der Linden YM;
    Acta Oncol; 2017 Dec; 56(12):1720-1727. PubMed ID: 28893119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT RT: a prospective pilot clinical trial of Scan-Plan-QA-Treat stereotactic body radiation therapy for painful osseous metastases.
    Wilson DD; Alonso CE; Sim AJ; Peck T; Handsfield LL; Chen Q; Blackhall L; Showalter TN; Reardon KA; Read PW
    Ann Palliat Med; 2019 Jul; 8(3):221-230. PubMed ID: 30691281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
    van der Velden JM; Peters M; Verlaan JJ; Versteeg AL; Zhang L; Tsao M; Danjoux C; Barnes E; van Vulpen M; Chow E; Verkooijen HM
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):859-866. PubMed ID: 29063851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases.
    Pielkenrood BJ; Gal R; Kasperts N; Verhoeff JJC; Bartels MMTJ; Seravalli E; van der Linden YM; Monninkhof EM; Verlaan JJ; van der Velden JM; Verkooijen HM
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1203-1215. PubMed ID: 35017007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What Factors are Associated With Quality Of Life, Pain Interference, Anxiety, and Depression in Patients With Metastatic Bone Disease?
    van der Vliet QM; Paulino Pereira NR; Janssen SJ; Hornicek FJ; Ferrone ML; Bramer JA; van Dijk CN; Schwab JH
    Clin Orthop Relat Res; 2017 Feb; 475(2):498-507. PubMed ID: 27752988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.